title: Meta-analysis: efficacy of therapeutic regimens in ongoing variceal bleeding.
abstract: OBJECTIVE
  Variceal bleeding is a major cause of mortality in liver cirrhosis. Therapeutic options include medical (vasoconstrictive/vasoactive drugs) and endoscopic (sclerotherapy/ligation) treatments. Most studies evaluating acute esophageal bleeding have included patients with both ongoing and recent bleeding. Therefore therapeutic efficacy in ongoing bleeding may not have been adequately determined in these studies. A meta-analysis was performed for two reasons: first to compare directly the various treatments in the case of ongoing bleeding, as this would not be accomplished by a single trial, and secondly, to determine the success rates of each treatment option based on a larger number of patients.
  
  
  METHODS
  An extensive Medline search identified 13 randomized controlled trials with precise statements of the number of patients with ongoing bleeding and their clinical outcomes. All studies followed a similar design and a Q test excluded heterogeneity of the studies. Data were pooled and cumulative success rates were calculated.
  
  
  RESULTS
  Ligation appeared to be the most effective treatment (91.0 %, 95 % CI 82.4-96.3 %); it was significantly more successful than vasoconstrictive treatment (vasopressin/terlipressin 68.7 %, 61.7-75.2 %; P < 0.002, chi-squared-test) or vasoactive treatment (somatostatin/octreotide, 75.9 %, 68.1-82.6 %; P < 0.02) treatment, but was not statistically better than sclerotherapy (81.1 %, 71.7-88.4 %). The latter therapy was not statistically superior to medical treatment options. Calculations of estimated true effects, which take into account the weight of each study, rendered similar results.
  
  
  CONCLUSIONS
  Ligation is the most effective treatment option. No significant difference was found between the efficacy of sclerotherapy and treatment with somatostatin or octreotide.
authors.affiliation: Klinikum der Universität München, Medizinische Poliklinik-Innenstadt, Germany. mgross@pk-i.uni-muenchen.de
authors.forename: M
authors.initials: M
authors.lastname: Gross
authors.forename: U
authors.initials: U
authors.lastname: Schiemann
authors.forename: A
authors.initials: A
authors.lastname: Mühlhöfer
authors.forename: W G
authors.initials: WG
authors.lastname: Zoller
mesh_terms: D000328:Adult; D044466:Asian People; D016001:Confidence Intervals; D004724:Endoscopy; D005060:Europe; D005260:Female; D006470:Hemorrhage / Q000150:complications / Q000628:therapy*; D006801:Humans; D008026:Ligation / Q000295:instrumentation; D008099:Liver / Q000098:blood supply; D008103:Liver Cirrhosis / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009656:North America; D011446:Prospective Studies; D015911:Sclerotherapy / Q000295:instrumentation; D013997:Time Factors; D016896:Treatment Outcome; D014648:Varicose Veins / Q000150:complications / Q000628:therapy*